These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 21170360)
1. HIV capsid is a tractable target for small molecule therapeutic intervention. Blair WS; Pickford C; Irving SL; Brown DG; Anderson M; Bazin R; Cao J; Ciaramella G; Isaacson J; Jackson L; Hunt R; Kjerrstrom A; Nieman JA; Patick AK; Perros M; Scott AD; Whitby K; Wu H; Butler SL PLoS Pathog; 2010 Dec; 6(12):e1001220. PubMed ID: 21170360 [TBL] [Abstract][Full Text] [Related]
2. Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes. Lamorte L; Titolo S; Lemke CT; Goudreau N; Mercier JF; Wardrop E; Shah VB; von Schwedler UK; Langelier C; Banik SS; Aiken C; Sundquist WI; Mason SW Antimicrob Agents Chemother; 2013 Oct; 57(10):4622-31. PubMed ID: 23817385 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein. Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C J Virol; 2017 May; 91(9):. PubMed ID: 28202766 [TBL] [Abstract][Full Text] [Related]
4. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization. Shi J; Zhou J; Shah VB; Aiken C; Whitby K J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083 [TBL] [Abstract][Full Text] [Related]
5. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid. Kortagere S; Madani N; Mankowski MK; Schön A; Zentner I; Swaminathan G; Princiotto A; Anthony K; Oza A; Sierra LJ; Passic SR; Wang X; Jones DM; Stavale E; Krebs FC; Martín-García J; Freire E; Ptak RG; Sodroski J; Cocklin S; Smith AB J Virol; 2012 Aug; 86(16):8472-81. PubMed ID: 22647699 [TBL] [Abstract][Full Text] [Related]
6. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors. Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities. Sun L; Dick A; Meuser ME; Huang T; Zalloum WA; Chen CH; Cherukupalli S; Xu S; Ding X; Gao P; Kang D; De Clercq E; Pannecouque C; Cocklin S; Lee KH; Liu X; Zhan P J Med Chem; 2020 May; 63(9):4790-4810. PubMed ID: 32298111 [TBL] [Abstract][Full Text] [Related]
8. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication. Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656 [TBL] [Abstract][Full Text] [Related]
9. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein. Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry. Zhou J; Price AJ; Halambage UD; James LC; Aiken C J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731 [TBL] [Abstract][Full Text] [Related]